logo
The £12 at-home prostate cancer test that could save you weeks of waiting for a GP

The £12 at-home prostate cancer test that could save you weeks of waiting for a GP

Telegrapha day ago

It's a slightly odd moment when I fire the little spring-loaded lancet into my own hand and, despite my attempts to bleed neatly, the kitchen table takes on a crime-scene feel. I've waited until family members are out and I'm able to process results alone, decide on next steps, and set my face if needed.
I'm taking a prostate health blood test that I bought in Sainsbury's. It uses the little white plastic result tray familiar from Covid, capturing a drop of blood. The makers of the test I'm using say take up has increased 69 per cent since launch, two years ago. More and more of us are checking ourselves in this way, but what does it entail and what do you need to know?
There is something satisfying about taking some control of your own health, and that's how it feels to take a prostate health test in your kitchen. It requires some self-education and a little caution, but I'm a fan. There are two kinds currently available – the pin-prick quick response that I am trying, and those that require a larger sample to be sent to a lab. Other commercial screenings exist, but have not been rolled out for home use yet.
The commercial laboratory tests are much the same as an NHS blood test, only without the doctor to interpret results and place them in context (many provide this as an optional extra). Both measure PSA, a naturally occurring protein that can be an indicator of cancer.
Testing at home for medical conditions is a booming business, with the global at-home medical testing market estimated at $7.4 million (£5.5m) in 2024.
I have to confess, the idea of peering into my health in the privacy of my own home is very appealing – especially while there is no national screening programme. The faff of arranging appointments, the vulnerable feeling that overtakes you as you walk through the door of the surgery, and the worry about managing feelings: all of this makes lightly stabbing myself at the kitchen table feel more than worth it.
Pros of self-test kits
They are (reasonably) accurate
Nick James, professor of prostate and bladder cancer research at the Institute of Cancer Research, and the Royal Marsden Hospital in London says, 'We did a bit of research on tests of this type and they weren't bad, to be honest. We dual-tested 50-100 [patients], comparing our lab results with their results – there was some inaccuracy at the borderline between normal and abnormal, but did that matter? Probably not. Once you have a properly abnormal PSA they will be accurate'.
They are quick
Prof James says: 'It is quite a good way of circumventing the initial chat with the GP. Most things in life you have control of, you want a pizza you pick up the phone and it arrives. It's only in medicine where you have to be grateful for what the NHS gives you, which might be great or it might be rubbish.'
They are a useful start
'There's not much you can do wrong with them really,' says Prof James. 'If you have the test and it's normal, probably the NHS test would be normal too, if it's abnormal that should allow you to drive a referral. I tried to get an NHS PSA just to see the process, and it took me weeks and weeks.'
They are cheap and easy
Frederick Manduca is a director of Newfoundland Diagnostics, which makes the lateral flow PSA test I used. He says: 'There's a convenience factor, you can buy the test in Sainsbury's with your shopping and the result is there within ten minutes. It retails at £12, so you can screen regularly. It's easy to use. You only need a few droplets of blood and you can put it through the lateral flow test.'
They are set up for the most at-risk group
Newfoundland tests record any PSA score up to four as normal. 'We chose four as the dividing line,' says Manduca. 'It's all based on what we see as the most helpful cut-off for age. If we were screening 20-40 year olds the cut off would be much lower, but because that group is at such low risk, we weren't focused on them. At 70-plus, an abnormal result comes in between 4 and 5 PSA, between 50 and 70, anything from 4.00 upwards is definitely raised. It's the mid-point for that age range.'
Cons of self-test kits
Interpreting the results
It's about self-education. PSA is not a cancer indicator in itself. Manduca says: 'The key is people understanding when they should test and what the results mean – this is a test for a protein the body produces, it's not a test for prostate cancer.' The Newfoundland tests come with a leaflet produced in conjunction with a cancer charity.
How do the self-test kits compare to a clinical screening?
There has been some controversy about this. A BBC report into the rapid response tests (no brands were specified) said: 'Of the five kits analysed by the BBC, one did not produce a readable result; three came back all clear; but one did show a solid dark line, indicating a PSA level above 4.0 ug/l. A private blood test taken the same day and sent to a laboratory, showed a much lower reading of 0.27 ug/l.'
Manduca says the Newfoundland kits are tested against approved independent lab results: '92 per cent of the time the lab tests and the rapid tests were agreeing. There are slight deviations and cut-offs, if you were right on a boundary number, say 3.9.'
He warns, however, that there are less reliable tests sold online and consumers need to check for official approvals before buying.
The Prostate Cancer UK site says: 'We recommend that if you're worried about prostate cancer and want a PSA blood test, you should speak to your GP. It's crucial that, before you have a PSA blood test, you get balanced information or counselling from a healthcare professional, and that you get professional follow-up about your result and what to do next.'
How to read your self-test kit results
Any PSA is far from conclusive. Using a cheap and reasonably accurate home test can allow you to track your number and spot any changes. An NHS PSA test is also not definitive, and a high number should mark the start of an investigation. Figures for 'normal' PSA scores by age are available online, but any worries need full investigation with MRI scans via the doctor.
Fredrick Manduca says: 'It's a tool in an overall toolkit. A lot of men don't know that if do they have a raised PSA only one-in-four of them will have prostate cancer. The general concept is for someone to test every year or every two years depending on how at risk they are, and see if there's a change.'
My test, by the way, was normal, matching my most recent PSA which came in under 4.00. But I shall continue to monitor myself, looking for tell-tale changes.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

I tried CeraVe's new foam cleanser – and it's not what I expected
I tried CeraVe's new foam cleanser – and it's not what I expected

The Independent

time34 minutes ago

  • The Independent

I tried CeraVe's new foam cleanser – and it's not what I expected

Fans of CeraVe will relish the brand's affordable, no-nonsense approach to facial cleansing. Do away with the essential oils, scrap the yellow and pink colouring, and hand over what's left: a targeted approach to bacteria and grime, specific to each skin type. It currently has a range of face cleansers, from an exfoliating salicylic acid formula (£10.80, to a hydrating one (£9.36, for dry, delicate complexions. And CeraVe has just added another to its cleansing roster aimed at normal to combination skin types. As someone who loves CeraVe, I was excited to hear word of a new launch: the balancing air foam cleanser (£10.86, But, I was dubious of the formula as I'm not normally a fan of foams. By design, foams require surfactants – ingredients that help lift dirt and oil but can often be drying. For years, brands like Clearasil and Neutrogena leaned into this, creating foaming face washes that stripped the skin under the guise of controlling acne and shine. Ironically, such formulas can backfire. Harsh surfactants like sodium lauryl sulfate (SLS) may compromise the skin's surface, creating tiny fissures that allow sebum to leak through. Dr Stefanie Williams, a registered dermatologist and medical director at Eudelo skin clinic, explained: 'Foaming cleansers, often marketed for oily or acne-prone skin, can actually make things worse when overused or poorly formulated as they can damage the skin barrier and disrupt the epidermis, triggering reactive oil production and congestion.' The result? More oil, more shine, and a disrupted barrier. So when CeraVe used the term 'balancing' to describe this cleanser, I had my doubts. The question is, does it buck the cleanser curve? How I tested I used CeraVe's balancing air foam cleanser for 10 days in the mornings and evenings, the latter as a second cleanse after removing make-up. I applied two to three pumps of the formula to my skin, massaging it into the surface before wiping it off with a hot flannel. I paid attention to the texture, feel and post-use results, noting any changes to the tightness or hydration of my skin. I also considered the value for money across ingredients and packaging, stacking my real-time review up against its on-paper benefits. Here's how I got on. Why you can trust IndyBest reviews Lucy Smith is The Independent 's beauty writer. She has grown increasingly familiar with CeraVe – from its revitalising eye cream to its vitamin C serum. Regarding cleansers, she's covered multiple in her five years in the industry, including Elemis, The Inkey List and more. She's interviewed numerous skincare experts, from plastic surgeons like Dr Rebecca Rollett to dermatologists and aestheticians to understand different ingredients and formulations.

American deaths from this alcohol-linked disease have doubled in 20 years
American deaths from this alcohol-linked disease have doubled in 20 years

The Independent

time40 minutes ago

  • The Independent

American deaths from this alcohol-linked disease have doubled in 20 years

Alcohol-related liver disease deaths in the U.S. have roughly doubled between 1999 and 2022, with a significant increase during and after the Covid -19 pandemic, according to a group of physicians. Mortality rates from alcohol-associated liver disease surged from 6.7 to 12.5 deaths per 100,000 people during the studied period, with a higher annual increase among women and concerning trends among young people. American Indian or Alaska Native populations experienced the highest death rates, increasing from approximately 25 to nearly 47 per 100,000 between 1999 and 2022. Mortality rates surged an annual average of 9 percent from 2018 to 2022, attributed to pandemic-related stressors like financial insecurity and social isolation, leading to increased drinking. The findings indicate an urgent need for enhanced screening, improved addiction treatment access, and targeted interventions for high-risk groups, doctors say.

Future of major research facility remains in doubt
Future of major research facility remains in doubt

BBC News

timean hour ago

  • BBC News

Future of major research facility remains in doubt

The future of a major science and defence facility remains in the balance, despite government promises that it would be confirmed during the chancellor's spending UK Health Security Agency at Porton Down in Wiltshire researches how to tackle the world's most infectious diseases, and prepare the UK for future facility's move to Harlow in Essex was first announced in 2015, but has been been postponed from its initial moving date of 2024, due to spiralling no mention of the facility in Chancellor Rachel Reeves' statement, Salisbury MP John Glen asked whether the move was going ahead, but was told it was up to the Health Secretary. In her full response, the chancellor said that the government had given a "significant sum of money" to the Department of Health & Social Care and that it will be for the Health Secretary to make a of the spending review, the government had explicitly stated that a decision would be announced concerning the Glen says that despite searching for more information, he was unable to find a more definite answer."I scoured all the press releases and all the information I could find, and the decision is not apparent to us yet," he said."It is being kicked down the road. If they are going to move ahead with it it's going to cost a lot of money, with grave uncertainties and a lot of insecurity for people who work at Porton along the way." Council leader Ian Thorn said if the facility were to leave Wiltshire, it would be a "huge mistake" on the government's part."Beyond the health security agencies facilities, we have some of the most extraordinary research and development facilities in the world at Porton Down, much of it delivered by Wiltshire Council and our partners," he said."If you want to focus your attention in terms of delivering fantastic services, providing the right environment for highly skilled technicians and scientists, then staying in Wiltshire is clearly the right thing they should do."

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store